DocSym
β
Searchsearch
Search
(Q56.2) Female pseudohermaphroditism, not elsewhere classified
More details coming soon
7 198 in individuals diagnosis female pseudohermaphroditism, not elsewhere classified confirmed
Diagnosis female pseudohermaphroditism, not elsewhere classified is diagnosed Women are 18.12% more likely than Men
2 947
Men receive the diagnosis female pseudohermaphroditism, not elsewhere classified
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
4 251
Women receive the diagnosis female pseudohermaphroditism, not elsewhere classified
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease female pseudohermaphroditism, not elsewhere classified - Men aged 0 and Women aged 15-19
In Men diagnosis is most often set at age 0-5, 10-24, 35-39, 60-64
Less common in men the disease occurs at Age 5-9, 25-34, 40-59, 65-95+Less common in women the disease occurs at Age 25-29, 35-44, 50-95+
In Women diagnosis is most often set at age 0-24, 30-34, 45-49
Disease Features female pseudohermaphroditism, not elsewhere classified
Absence or low individual and public risk
Female pseudohermaphroditism, not elsewhere classified - what does this mean
Female pseudohermaphroditism, not elsewhere classified, is caused by a genetic disorder in which the ovaries and testes are both present in the same individual. this condition is most commonly caused by a mutation in the sry gene, which is responsible for the development of the male reproductive system. in some cases, the mutation may result in the production of both male and female hormones, leading to the development of both male and female physical characteristics.
What happens during the disease - female pseudohermaphroditism, not elsewhere classified
Female pseudohermaphroditism, not elsewhere classified is a condition in which a female's reproductive organs are not completely developed. it can be caused by a variety of factors including genetic mutations, environmental exposure, or endocrine imbalances. these can lead to an abnormal amount of hormones being produced, which can cause the reproductive organs to not develop properly. this can lead to a variety of symptoms, such as ambiguous genitalia, infertility, and other reproductive issues.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical Examination
- Blood Tests
- Genetic Testing
- Imaging Tests
- Hormone Level Tests
- Urine Tests
- Ultrasound
Treatment and Medical Assistance
Main Goal: Treating the symptoms of Female pseudohermaphroditism, not elsewhere classified.
- Administering hormone therapy to reduce the effects of testosterone on the body.
- Prescribing medications to reduce the production of testosterone in the body.
- Performing surgical procedures to remove any male genitalia present.
- Performing reconstructive surgery to create female genitalia.
- Counseling to help the patient cope with the physical and emotional effects of the condition.
- Regular monitoring of hormone levels and other parameters to ensure the effectiveness of treatment.
8 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Female pseudohermaphroditism, not elsewhere classified - Prevention
Female pseudohermaphroditism, not elsewhere classified, can be prevented by avoiding exposure to environmental toxins such as pesticides, industrial chemicals, and heavy metals, and by eating a balanced diet with adequate amounts of essential nutrients. in addition, regular medical checkups and screening tests should be done to detect any potential problems early.